Aspira Pathlab & Diagnostics

Aspira Pathlab & Diagnostics Receivables

The Accounts Receivable of Aspira Pathlab & Diagnostics (540788.BO) as of Nov 3, 2026 is 23.52 M INR. In the previous year, Accounts Receivable was 22.42 M INR — a change of 4.88% (higher).

Receivables

23.52 MINR

YoY

4.88%

Last updated:

Accounts Receivable of Aspira Pathlab & Diagnostics is 2025 23.52 M INR. Accounts Receivable of Aspira Pathlab & Diagnostics was 2024 22.42 M INR. It decreases by 4.88% higher compared to the previous year.

The Aspira Pathlab & Diagnostics Receivables history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Receivables
Date
Receivables
Jan 1, 2018
3.55 M INR
Jan 1, 2019
7.96 M INR
Jan 1, 2020
6.05 M INR
Jan 1, 2021
17.03 M INR
Jan 1, 2022
44.91 M INR
Jan 1, 2023
23.39 M INR
Jan 1, 2024
22.42 M INR
Jan 1, 2025
23.52 M INR
The Aspira Pathlab & Diagnostics Receivables history
YEARReceivablesYoY
23.52 MINR+4.88%
22.42 MINR-4.12%
23.39 MINR-47.93%
44.91 MINR+163.76%
17.03 MINR+181.64%
6.05 MINR-24.06%
7.96 MINR+124.41%
3.55 MINR+307.68%
870,200.00INR+47.27%
590,900.00INR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Aspira Pathlab & Diagnostics Stock analysis

What does Aspira Pathlab & Diagnostics do? Aspira Pathlab & Diagnostics Ltd generates revenue through pathology investigation services, radiology investigation services, and health packages at its diagnostic centers in Mumbai. The company offers specialized tests such as the Shanti Screening Test, COVID-19 Antibody Test, and COVID-19 RT-PCR Test, which are part of its diagnostic services portfolio. Customers include individuals seeking health screenings, patients requiring medical diagnostics, and healthcare providers who refer clients to its facilities. The firm's services are segmented into pathology, radiology, and health packages, with a focus on high-demand tests like COVID-19 detection profiles. The company's revenue streams are derived from conducting various pathological investigations across branches like biochemistry, hematology, and microbiology. Its health packages and pathology tests, including the COVID-19 Detection Profile 1 and 2, cater to both individual and institutional clients. The firm operates within the healthcare sector, providing diagnostic solutions for patients and medical professionals in Mumbai, with a particular emphasis on pandemic-related testing services during the global health crisis. Aspira Pathlab & Diagnostics Ltd monetizes its diagnostic capabilities through a mix of routine pathology services and specialized health packages. The Shanti Screening Test and other COVID-19-related tests form a significant portion of its revenue, especially during periods of high demand for pandemic testing. The company serves a broad customer base, including individuals, clinics, and hospitals that rely on its diagnostic expertise for accurate medical assessments. Aspira Pathlab & Diagnostics is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Aspira Pathlab & Diagnostics stock

Accounts Receivable of Aspira Pathlab & Diagnostics is 23.52 M INR in 2025.

Accounts Receivable of Aspira Pathlab & Diagnostics changed from 22.42 M INR to 23.52 M INR, representing a 4.88% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Accounts Receivable Aspira Pathlab & Diagnostics since 2006 – with annual values, charts, and detailed analysis.

Receivables represent money owed to the company by customers for goods or services delivered. High receivables relative to revenue may indicate collection issues.

Accounts Receivable's INR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Accounts Receivable's Aspira Pathlab & Diagnostics historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Aspira Pathlab & Diagnostics

All Key Metrics — Aspira Pathlab & Diagnostics